N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
about
Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms.Autoimmune phenotypes in schizophrenia reveal novel treatment targets.N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial
P2860
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
N-acetylcysteine in a Double-B ...... Treatment in Early Psychosis.
@en
N-acetylcysteine in a Double-B ...... Treatment in Early Psychosis.
@nl
type
label
N-acetylcysteine in a Double-B ...... Treatment in Early Psychosis.
@en
N-acetylcysteine in a Double-B ...... Treatment in Early Psychosis.
@nl
prefLabel
N-acetylcysteine in a Double-B ...... Treatment in Early Psychosis.
@en
N-acetylcysteine in a Double-B ...... Treatment in Early Psychosis.
@nl
P2093
P2860
P50
P356
P1476
N-acetylcysteine in a Double-B ...... Treatment in Early Psychosis.
@en
P2093
Ann Cousins
Carina Ferrari
Chin B Eap
Joanne Wojcik
Luis Alameda
Margot Fournier
Martine Cleusix
Mehdi Gholam-Rezaee
Michel Cuenod
Philipp S Baumann
P2860
P304
P356
10.1093/SCHBUL/SBX093
P407
P577
2018-02-01T00:00:00Z